Ethereum treasury-listed company Huajian Medical acquires Guofu Quantum equity for HKD 3.142 billions to advance its RWA exchange strategy

ChainCatcher News, according to an announcement from the Hong Kong Stock Exchange, Hong Kong-listed Ethereum treasury company Huajian Medical announced the acquisition of a 20.31% stake in Guofu Quantum for approximately HKD 3.142 billions to advance its RWA exchange strategy. The transaction will be paid by allotment and issuance of consideration shares at an issue price of HKD 9.69 per share.

After the acquisition is completed, Huajian Medical will become the major shareholder of Guofu Quantum and will include it in its financial statements using the equity method. This acquisition is part of Huajian Medical's efforts to advance its RWA (Real World Asset) exchange strategy, achieving a closed-loop ecosystem from the asset side to the trading side, and will also lay out plans in the stablecoin market. In August this year, Huajian Medical announced the official launch of its global enhanced Ethereum treasury strategy with a downside protection mechanism, making Ethereum its core reserve asset.